Clinical Trial Update: Zinde Zihin Program to Reduce Alzheimer's Disease Risk in Adults Aged 65 and Older [NA]

View source ↗

Summary

A completed clinical trial (NCT07244848) evaluating the Zinde Zihin program intended to reduce Alzheimer's disease risk in adults 65 and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Burdur Mehmet Akif Ersoy University | Conditions: Cognitive Decline, Aging | NA | Status: COMPLETED